0001209191-22-036403.txt : 20220613
0001209191-22-036403.hdr.sgml : 20220613
20220613172138
ACCESSION NUMBER: 0001209191-22-036403
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220609
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McHugh Julie
CENTRAL INDEX KEY: 0001487179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 221012618
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 237-5300
MAIL ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-09
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001487179
McHugh Julie
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
1
0
0
0
Common Stock
2022-06-09
4
A
0
6245
0.00
A
16095
D
Stock Option (right to buy)
6.11
2022-06-09
4
A
0
16854
0.00
A
2032-06-09
Common Stock
16854
16854
D
Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common
Stock are scheduled to vest on June 9, 2023.
Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is
scheduled to vest ratably on each of the first 12 monthly anniversaries of June 9, 2022.
/s/ John W. LaRocca, Attorney-in-Fact for Julie McHugh
2022-06-13